C103H106Br2Cl3F3N16O9S3 — CID 158208567
4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-2H-indazol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide;4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-propan-2-ylpiperazine-1-carboxamide;4-[(2S,3S)-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide (PubChem CID 158208567) has the molecular formula C103H106Br2Cl3F3N16O9S3 and a molecular weight of 2131.45 g/mol. Its IUPAC name is 4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-2H-indazol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide;4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-propan-2-ylpiperazine-1-carboxamide;4-[(2S,3S)-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide.
| Compound Name | 4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-2H-indazol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide;4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-propan-2-ylpiperazine-1-carboxamide;4-[(2S,3S)-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide |
|---|---|
| PubChem CID | 158208567 |
| Molecular Formula | C103H106Br2Cl3F3N16O9S3 |
| Molecular Weight | 2131.45 g/mol |
| Exact Mass | 2126.49 |
| IUPAC Name | 4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-2H-indazol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide;4-[(2S,3S)-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxopyrrolidine-3-carbonyl]-N-propan-2-ylpiperazine-1-carboxamide;4-[(2S,3S)-2-(6-chloro-1H-indol-3-yl)-3-(4-methylphenyl)sulfanyl-5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]pyrrolidine-3-carbonyl]-N-ethylpiperazine-1-carboxamide |
| SMILES | CCNC(=O)N1CCN(C(=O)[C@]2(Sc3ccc(C)cc3)CC(=O)N(Cc3ccc(Br)cc3)[C@H]2c2[nH]nc3cc(Cl)ccc23)CC1.CCNC(=O)N1CCN(C(=O)[C@]2(Sc3ccc(C)cc3)CC(=O)N(Cc3ccc(C(F)(F)F)cc3)[C@H]2c2c[nH]c3cc(Cl)ccc23)CC1.Cc1ccc(S[C@@]2(C(=O)N3CCN(C(=O)NC(C)C)CC3)CC(=O)N(Cc3ccc(Br)cc3)[C@H]2c2c[nH]c3cc(Cl)ccc23)cc1 |
| InChI | InChI=1S/C35H37BrClN5O3S.C35H35ClF3N5O3S.C33H34BrClN6O3S/c1-22(2)39-34(45)41-16-14-40(15-17-41)33(44)35(46-27-11-4-23(3)5-12-27)19-31(43)42(21-24-6-8-25(36)9-7-24)32(35)29-20-38-30-18-26(37)10-13-28(29)30;1-3-40-33(47)43-16-14-42(15-17-43)32(46)34(48-26-11-4-22(2)5-12-26)19-30(45)44(21-23-6-8-24(9-7-23)35(37,38)39)31(34)28-20-41-29-18-25(36)10-13-27(28)29;1-3-36-32(44)40-16-14-39(15-17-40)31(43)33(45-25-11-4-21(2)5-12-25)19-28(42)41(20-22-6-8-23(34)9-7-22)30(33)29-26-13-10-24(35)18-27(26)37-38-29/h4-13,18,20,22,32,38H,14-17,19,21H2,1-3H3,(H,39,45);4-13,18,20,31,41H,3,14-17,19,21H2,1-2H3,(H,40,47);4-13,18,30H,3,14-17,19-20H2,1-2H3,(H,36,44)(H,37,38)/t32-,35-;31-,34-;30-,33-/m000/s1 |
| InChIKey | GBUCWULXIWTRCH-UMTPFVGGSA-N |
| XLogP | 20.35 |
| TPSA | 279.14 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 139 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2131.45 |
| LogP ≤ 5 | 20.35 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 13 |